Siarot, Jurhamae S.

HRN: 29-31-15  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
CO-AMOXICLAV 625MG (TAB)
07/20/2026
07/27/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE; Thinly MSAF
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: